Latest Insider Transactions at Bio Xcel Therapeutics, Inc. (BTAI)
This section provides a real-time view of insider transactions for Bio Xcel Therapeutics, Inc. (BTAI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioXcel Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioXcel Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+13.99%
|
-
|
|
Mar 15
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+20.58%
|
-
|
|
Mar 15
2024
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
-
|
|
Mar 15
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+27.83%
|
-
|
|
Mar 15
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+22.28%
|
-
|
|
Mar 15
2024
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+28.76%
|
-
|
|
Mar 14
2024
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.31%
|
-
|
|
Mar 14
2024
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+7.49%
|
-
|
|
Mar 14
2024
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+12.69%
|
-
|
|
Mar 14
2024
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,610
+6.97%
|
-
|
|
Mar 14
2024
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+13.55%
|
-
|
|
Dec 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+8.1%
|
-
|
|
Dec 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+7.49%
|
-
|
|
Dec 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.5%
|
-
|
|
Dec 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+14.54%
|
-
|
|
Dec 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+15.68%
|
-
|
|
Sep 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.71%
|
-
|
|
Sep 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,610
+8.1%
|
-
|
|
Sep 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+18.59%
|
-
|
|
Sep 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+8.81%
|
-
|
|
Sep 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+17.01%
|
-
|
|
Jun 16
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-15.69%
|
$600,000
$20.93 P/Share
|
|
Jun 16
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.03%
|
$0
$0.41 P/Share
|
|
Jun 15
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-24.09%
|
$630,000
$21.66 P/Share
|
|
Jun 15
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.03%
|
$0
$0.41 P/Share
|
|
Jun 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+4.94%
|
-
|
|
Jun 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+9.66%
|
-
|
|
Jun 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,609
+6.14%
|
-
|
|
Jun 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+20.5%
|
-
|
|
Jun 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+22.84%
|
-
|
|
May 22
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
6,500
-14.84%
|
$162,500
$25.79 P/Share
|
|
May 15
2023
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
1,785
-29.1%
|
$48,195
$27.32 P/Share
|
|
May 15
2023
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-76.92%
|
$135,000
$27.17 P/Share
|
|
May 14
2023
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.9%
|
-
|
|
May 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+43.48%
|
-
|
|
May 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+32.68%
|
-
|
|
Apr 06
2023
|
Krishnan Nandabalan Director |
SELL
Open market or private sale
|
Direct |
60,000
-100.0%
|
$1,020,000
$17.32 P/Share
|
|
Apr 06
2023
|
Krishnan Nandabalan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
$0
$0.41 P/Share
|
|
Mar 21
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
30,000
-34.38%
|
$570,000
$19.93 P/Share
|
|
Mar 21
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+39.53%
|
$0
$0.41 P/Share
|
|
Mar 20
2023
|
Vimal Mehta CEO and President |
SELL
Open market or private sale
|
Direct |
34,500
-23.11%
|
$621,000
$18.54 P/Share
|
|
Mar 20
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+37.32%
|
$0
$0.41 P/Share
|
|
Mar 15
2023
|
Vincent O'Neill Officer |
SELL
Open market or private sale
|
Direct |
845
-40.55%
|
$16,055
$19.7 P/Share
|
|
Mar 15
2023
|
Frank Yocca Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
985
-9.4%
|
$18,715
$19.69 P/Share
|
|
Mar 15
2023
|
Richard I Steinhart Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,084
-58.15%
|
$39,596
$19.5 P/Share
|
|
Mar 15
2023
|
Javier Rodriguez Officer |
SELL
Open market or private sale
|
Direct |
950
-45.56%
|
$18,050
$19.62 P/Share
|
|
Mar 14
2023
|
Vincent O'Neill Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+50.0%
|
-
|
|
Mar 14
2023
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,437
+33.85%
|
-
|
|
Mar 14
2023
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+16.59%
|
-
|
|
Mar 14
2023
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+36.77%
|
-
|